Literature DB >> 32245897

ProPSMA: A Callout to the Nuclear Medicine Community to Change Practices with Prospective, High-Quality Data.

Michael S Hofman1.   

Abstract

Entities:  

Year:  2020        PMID: 32245897      PMCID: PMC7198385          DOI: 10.2967/jnumed.120.245647

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  3 in total

1.  Accuracy of Dose Calibrators for 68Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment.

Authors:  Dale L Bailey; Michael S Hofman; Nicholas J Forwood; Graeme J O'Keefe; Andrew M Scott; Winifred M van Wyngaardt; Bonnie Howe; Olga Kovacev; Roslyn J Francis
Journal:  J Nucl Med       Date:  2018-01-11       Impact factor: 10.057

2.  A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Authors:  Michael S Hofman; Declan G Murphy; Scott G Williams; Tatenda Nzenza; Alan Herschtal; Richard De Abreu Lourenco; Dale L Bailey; Ray Budd; Rodney J Hicks; Roslyn J Francis; Nathan Lawrentschuk
Journal:  BJU Int       Date:  2018-06-03       Impact factor: 5.588

3.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Authors:  Michael S Hofman; Nathan Lawrentschuk; Roslyn J Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood; Dickon Hayne; Emma Link; Petra Marusic; Anetta Matera; Alan Herschtal; Amir Iravani; Rodney J Hicks; Scott Williams; Declan G Murphy
Journal:  Lancet       Date:  2020-03-22       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.